USMLE Step 1 practice question: Neuroleptic malignant syndrome: dopamine D2 blockade
USMLE Step 1PsychiatryPharmacology
Which of the following best explains the pathophysiology of this patient's condition?
- Excess serotonergic stimulation of central 5-HT2A receptors
- Uncontrolled calcium release from the skeletal muscle sarcoplasmic reticulum
- Blockade of muscarinic receptors in central and peripheral tissues
- Dopamine D2 receptor blockade in the hypothalamus and nigrostriatal pathway
- Rebound sympathetic overactivity after abrupt withdrawal of a GABA agonist
Show answer and explanation
Correct answer: D. Dopamine D2 receptor blockade in the hypothalamus and nigrostriatal pathway
Fever, altered mental status, generalized lead-pipe rigidity, autonomic instability (tachycardia, labile blood pressure, diaphoresis) and a markedly elevated creatine kinase days after starting a high-potency antipsychotic indicate neuroleptic malignant syndrome (NMS). A dipstick positive for blood without erythrocytes reflects myoglobinuria from rhabdomyolysis, and leukocytosis is common.
NMS results from an abrupt reduction in central dopaminergic activity. Blockade of D2 receptors in the hypothalamus impairs heat dissipation and thermoregulation, blockade in the nigrostriatal pathway causes severe rigidity (which generates heat and breaks down muscle), and loss of dopaminergic modulation of descending pathways contributes to sympathetic dysregulation. Risk factors include high-potency first-generation antipsychotics, rapid dose escalation, parenteral administration, dehydration and agitation; NMS can also follow abrupt withdrawal of dopaminergic drugs such as levodopa in Parkinson disease. Symptoms usually begin within the first 2 weeks of treatment and evolve over 1 to 3 days.
Management starts with stopping the offending drug and providing supportive care: cooling, intravenous fluids to prevent kidney injury from myoglobin, and benzodiazepines for agitation. Dantrolene (to relax muscle) and bromocriptine or amantadine (to restore dopaminergic tone) are used in moderate to severe cases. NMS is distinguished from serotonin syndrome by normal or decreased reflexes and lead-pipe rigidity rather than hyperreflexia, clonus and diarrhea, and from anticholinergic toxicity by diaphoresis and normal pupils rather than dry skin and mydriasis.
Why the other options are wrong
- A. Excess serotonergic stimulation of central 5-HT2A receptors — Serotonin syndrome develops within hours of serotonergic drugs and causes hyperreflexia, clonus, mydriasis and diarrhea rather than lead-pipe rigidity.
- B. Uncontrolled calcium release from the skeletal muscle sarcoplasmic reticulum — This is malignant hyperthermia, an inherited ryanodine receptor defect triggered by volatile anesthetics or succinylcholine during anesthesia.
- C. Blockade of muscarinic receptors in central and peripheral tissues — Anticholinergic toxicity causes hot, dry skin, mydriasis, urinary retention and absent bowel sounds, without severe rigidity or a very high creatine kinase.
- E. Rebound sympathetic overactivity after abrupt withdrawal of a GABA agonist — Alcohol or benzodiazepine withdrawal causes tremor, hyperreflexia, hallucinations and seizures, not generalized lead-pipe rigidity with a creatine kinase above 20,000 U/L.
Key point
Neuroleptic malignant syndrome is caused by central dopamine D2 receptor blockade and presents with hyperthermia, lead-pipe rigidity, autonomic instability, altered mental status and markedly elevated creatine kinase.
Memory hook
NMS: no dopamine, so the thermostat breaks and muscles turn to lead pipes, with sky-high CK days after an antipsychotic.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free